Two Sigma Securities’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$412K Buy
+1,545
New +$361K 0.04% 684
2025
Q4
Sell
-1,162
Closed -$231K 1464
2025
Q3
$231K Buy
+1,162
New +$217K 0.03% 723
2024
Q4
Sell
-1,681
Closed -$251K 1705
2024
Q3
$251K Buy
+1,681
New +$227K ﹤0.01% 1943
2024
Q2
Sell
-1,875
Closed -$283K 2958
2024
Q1
$283K Sell
1,875
-1,157
-38% -$165K ﹤0.01% 2014
2023
Q4
$382K Buy
+3,032
New +$302K ﹤0.01% 1764
2023
Q2
Sell
-2,240
Closed -$240K 2762
2023
Q1
$240K Buy
+2,240
New +$256K ﹤0.01% 1915
2020
Q3
Sell
-1,428
Closed -$211K 1290
2020
Q2
$211K Buy
+1,428
New +$196K ﹤0.01% 1112

Other funds holding ASND

Two Sigma Securities's ASND Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 1,545 shares worth $412K. The stake represents 0.04% of the portfolio and ranks #684 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ASND as recently as Q3 2025.

Two Sigma Securities first reported a position in ASND in Q2 2020 and has held it in 7 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Two Sigma Securities held 1,545 shares of Ascendis Pharma A/S worth $412K as of Q2 2026.
  • Ascendis Pharma A/S was a new Two Sigma Securities position in Q2 2026.
  • Ascendis Pharma A/S made up 0.04% of Two Sigma Securities's portfolio in Q2 2026, its #684 holding.
  • Two Sigma Securities first reported a position in Ascendis Pharma A/S in Q2 2020 and has held it in 7 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.